World of DTC Marketing

DECEMBER 29, 2020

A key consideration is funding – public and private cash has been poured into the race for a Covid vaccine, pushing aside the usual financial concerns facing pharmaceutical companies. All vaccines go through clinical trials to test safety and effectiveness. The post How did pharma develop a vaccine so quickly?

Pharma 307

Pharma Food and Drug Administration Media Food 307

European Pharmaceutical Review

APRIL 18, 2024

What are the three main challenges of monitoring pharmaceuticals in the environment? Andreas Häner (AH): Roche, along with other pharmaceutical companies, acknowledges concerns about pharmaceuticals in the environment (PiE). A well-designed wastewater sampling plan will ensure that representative samples are collected.

Pharmaceutical 97

Pharmaceutical Manufacturing Management Doctors 97

European Pharmaceutical Review

JUNE 29, 2022

How does that impact the safety of the biologics? Safety is key to the development of any medicine, but the safety considerations linked to bioproduction are more complex because biologics are more sophisticated medicines than small molecules. This could lead to false positives or, even worse, false negatives! PathoQuest.

Ethics 98

Ethics Safety Manufacturing Medicine 98

European Pharmaceutical Review

APRIL 11, 2024

The pharmaceutical industry is becoming increasingly conscious of emissions and the importance of sustainable manufacturing. Globally, the pharmaceutical sector emitted around 52 megatonnes of CO 2 in 2015, the most recent period for which detailed numbers are available. appeared first on European Pharmaceutical Review.

Manufacturing 105

Manufacturing Pharmaceutical Engineering Pharmaceutical manufacturing 105

Pharma Pathway

JANUARY 24, 2023

Hetero Labs Limited-Walk-In Interviews for Quality Control/ Quality Assurance/ Engineering/ Safety -EHS On 29th Jan’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”. Dear, Greetings from Hetero…!!

Engineering 74

Engineering Safety Pharmaceutical Manufacturing 74

Pharma Marketing Network

JULY 19, 2023

Content Marketing as a Sales Driver: Unlocking Your Business Potential in the Pharmaceutical Industry Content marketing is a long-term strategy that can help businesses of all sizes generate leads, increase brand awareness, and drive sales.

Marketing 98

Marketing Pharmaceutical Sales Education 98

European Pharmaceutical Review

DECEMBER 4, 2023

The (bio)pharmaceutical industry is currently facing numerous hurdles in its path to high-efficiency production that are more complex and pressing than ever before. Simultaneously, there is increasing need for stringent quality control and traceability throughout the supply chain to ensure patient safety. principles.

Pharmaceutical manufacturing 105

Pharmaceutical manufacturing Manufacturing Pharmaceutical Pharmaceutical products 105

European Pharmaceutical Review

JULY 25, 2022

While the global trade of fake pharmaceuticals has long been a threat, the COVID-19 pandemic sent the fraudulent market into overdrive. Consequently, pharmaceutical manufacturers risk their reputation if impersonating products fail to deliver the expected quality or health impact. Defining ‘counterfeit’ and ‘falsified’.

Pharmaceutical 104

Pharmaceutical Medicine Pharmaceutical manufacturing Manufacturing 104

Pharma Marketing Network

JULY 19, 2023

For pharmaceutical companies, this means aligning sponsorships with causes that are related to health and wellness. For example, Pfizer, a leading pharmaceutical company, has a long history of sponsoring research into new drugs and treatments. This could help to ensure that everyone has access to the care they need.

Pharmaceutical 98

Pharmaceutical Healthcare Healthcare Education 98

World of DTC Marketing

NOVEMBER 1, 2020

Fauci, the country’s leading infectious-disease expert, said in a wide-ranging interview late Friday. Fauci, a leading member of the government’s coronavirus response, said the United States needed to make an “abrupt change” in public health practices and behaviors. We’re in for a whole lot of hurt. This is totally unacceptable.

Healthcare 188

Healthcare Healthcare Food and Drug Administration Distribution 188

European Pharmaceutical Review

OCTOBER 12, 2023

September 2023 saw a wave of new pharmaceutical manufacturing facility expansions and launches across Europe. While the data was based on responses from 292 manufacturers across all sectors, the outcomes are applicable to pharmaceutical manufacturing. Meath opened last month.

Pharmaceutical manufacturing 104

Pharmaceutical manufacturing Manufacturing Pharmaceutical Pharma 104

pharmaphorum

JANUARY 27, 2023

Having previously spoken with Dr Mullen three years ago when she was country medical director for the UK & Ireland at GSK – on the topic of patient centricity and embedding that focus within the core of a pharmaceutical company – our recent interview provided some interesting insights into the changing landscape of the industry.

Patients 111

Patients Pharmaceutical Medical Physicians 111

European Pharmaceutical Review

JUNE 13, 2024

Tell us about Ocugen’s lead programme, OCU400. Unlike conventional methods…modifier gene therapy…emphasises the importance of the broader biological system, potentially leading to more effective treatments.” What’s the latest and what’s next?

Manufacturing 145

Manufacturing Food and Drug Administration Engineering Safety 145

Impetus Digital

JANUARY 30, 2023

The pharmaceutical supply chain can be a difficult and demanding system to manage. But without patients, there would be no need for pharmaceuticals at all. Safety and Quality Control The safety and quality of medications are paramount when it comes to patient care. This is a guest article written by David L.

Pharmaceutical 67

Pharmaceutical Patients Safety Medical 67

eMediWrite

NOVEMBER 22, 2024

Becoming an outstanding product manager in the pharmaceutical industry and creating a top-tier brand demands a blend of strategic insight, industry expertise, and flawless execution. Deeply Understand Your Market and Audience To create a leading product, you need to understand the therapeutic area thoroughly.

Leads 52

Leads Pharma Marketing Healthcare Provider 52

European Pharmaceutical Review

FEBRUARY 27, 2024

Leading the MHRA – a five year journey Professor Graham Cooke, interim chair of the MHRA board, remarked that Dame June’s “leadership of the MHRA over the last five years, particularly during the COVID-19 pandemic, has been exceptional.” The post MHRA Chief Executive to step down appeared first on European Pharmaceutical Review.

Safety 111

Safety Pharmacology Medicine Education 111

European Pharmaceutical Review

OCTOBER 20, 2023

This cytokine drives the type-2 inflammatory loop in the skin, which leads to skin barrier dysfunction, itch, skin thickening and infection. The safety profile of lebrikizumab in ADjoin was found to be consistent with previous lebrikizumab studies in patients with moderate-to-severe atopic dermatitis.

Safety 105

Safety Pharmaceutical Patients Medicine 105

pharmaphorum

NOVEMBER 27, 2022

Supply chain issues have been rife in pharmaceuticals for a while, but current socio-economic challenges such as the conflict in Ukraine and the COVID-19 pandemic have led to extended wait times and higher prices for thousands of products. Here’s how applying automaton in pharmaceutical labs can help address these.

Pharma 105

Pharma Safety Pharmaceutical Manufacturing 105

European Pharmaceutical Review

OCTOBER 5, 2022

However, for the pharmaceutical industry, the challenge is not as simple as just switching materials. An industry that is among the world’s biggest polluters is caught in a balancing act between satisfying the health and safety demands of industry regulators and meeting the needs of modern eco-conscious consumers.

Pharma 98

Pharma Safety Pharmaceutical Manufacturing 98

European Pharmaceutical Review

MARCH 9, 2023

Highly potent active pharmaceutical ingredients (HPAPIs) are used in formulations for high potent drugs, owing to their ability to target precise disease cells including cancer cells. It’s a collaborative approach from safety, engineering, toxicology, and operations to have the most robust potent compound safety.

Safety 98

Safety Pharmacology Training Manufacturing 98

European Pharmaceutical Review

JANUARY 5, 2024

Utilising an add-on therapy for treatment-resistant schizophrenia (TRS) Newron Pharmaceuticals SPA has reported significant final, one-year results from its clinical trial 014/015, evaluating evenamide as an add-on therapy to antipsychotics in treatment-resistant schizophrenia (TRS).

Food and Drug Administration 111

Food and Drug Administration Medical Safety Patients 111

European Pharmaceutical Review

DECEMBER 5, 2024

Rapid microbiology methods have been gaining more visibility in the pharmaceutical microbiology industry due to the increased demand for faster turnaround times for microbiological results, especially for cell and gene therapy products where the urgency to deliver a safe and quality product to patients is within days.

Pharmaceutical 52

Pharmaceutical Manufacturing Marketing Leads 52

European Pharmaceutical Review

OCTOBER 20, 2022

Apogenix’s lead immunotherapy candidate, asunercept is a fully human fusion protein, consisting of the CD95 receptor and an IgG1 antibody. The Phase II trial investigated efficacy and safety of asunercept in 435 patients with moderate to severe COVID-19 disease.

Patients 105

Patients Safety Medicine Leads 105

European Pharmaceutical Review

SEPTEMBER 22, 2022

EBT-101, a CRISPR-Cas9 gene editing system delivered by adenovirus-associated virus vector serotype 9 (AAV9) has been administered to the first individual in a Phase I/II trial designed to establish its safety and efficacy. Biodistribution, pharmacodynamic, and efficacy assessments will also be conducted. “It

Patients 145

Patients Safety Medicine Physicians 145

European Pharmaceutical Review

OCTOBER 26, 2023

The submission includes comprehensive data from pre-clinical studies and thorough safety assessments, PharmaKure noted. According to the company’s website, its lead candidate PK051 combines an antidepressant and antipsychotic. PharmaKure is a clinical stage pharmaceutical company, spun out from the University of Manchester.

Safety 105

Safety Pharmaceutical Patients Medicine 105

European Pharmaceutical Review

SEPTEMBER 20, 2022

“Over the past 15 years and the experience from clinical practice has shown that in terms of efficacy, safety and immunogenicity they are comparable to their reference products and are therefore interchangeable,” commented EMA’s Executive Director, Emer Cooke. This was substantiated by safety data of over one million patient-treatment years.

Medicine 98

Medicine Side effects Safety Doctors 98

European Pharmaceutical Review

JUNE 16, 2023

With the adoption of digital technologies gaining traction in many industries, pharmaceutical companies must take advantage of digitalisation within its research and development (R&D) sector. This can lead to faster access to information, reduce the need for large cohorts and therefore an acceleration in progress in medical research.

Safety 111

Safety Electronics Recruitment Patients 111

European Pharmaceutical Review

JUNE 15, 2023

A paper published in the Journal of Pharmaceutical Research International has reviewed microbiological testing for medical devices and described their applications and challenges. However, the safety and efficacy of these devices can be compromised if they are not appropriately designed, manufactured, and maintained, the authors wrote.

Manufacturing 103

Manufacturing Medical Safety Transportation 103

Pharma Marketing Network

JULY 26, 2023

The Food and Drug Administration (FDA) plays a critical role in regulating the pharmaceutical industry and ensuring that medications and medical devices marketed to the public are safe, effective, and appropriately labeled.

Marketing 97

Marketing FDA Food and Drug Administration Pharmaceutical 97

European Pharmaceutical Review

MAY 15, 2023

HARMONIE investigated the efficacy and safety of a single intramuscular dose of nirsevimab. Agreed in March 2017, AstraZeneca leads development and manufacturing activities, and Sanofi leads commercialisation activities. The post RWE shows efficacy of nirsevimab for infant RSV appeared first on European Pharmaceutical Review.

Safety 104

Safety Leads Manufacturing Medicine 104

European Pharmaceutical Review

OCTOBER 23, 2023

Janssen Pharmaceutical Companies of Johnson & Johnson’s data were featured at the European Society for Medical Oncology (ESMO) 2023 Congress. Martin Vogel, EMEA Therapeutic Area Lead Oncology, Janssen-Cilag GmbH highlighted that “standard-of-care for BCG-unresponsive HR-NMIBC is radical cystectomy”.

Pharmaceutical 111

Pharmaceutical Safety Patients Leads 111

European Pharmaceutical Review

MARCH 6, 2023

PAH is a rare, progressive blood vessel disorder that can lead to right heart failure. The safety profile of M/T STCT was consistent with the known safety profiles of macitentan and tadalafil monotherapies and no new safety observations were made.

Safety 96

Safety Patients Pharmaceutical Medicine 96

European Pharmaceutical Review

JANUARY 17, 2023

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has granted a marketing authorisation for Ximluci ® (ranibizumab), a biosimilar referencing Lucentis®, to help treat a leading cause of blindness globally. First bispecific antibody approved in EU to combat leading causes of vision loss.

Manufacturing 104

Manufacturing Marketing Medicine Leads 104

European Pharmaceutical Review

OCTOBER 24, 2023

While meningococcal disease is uncommon, serious illness can lead to a fatal outcome within 24 hours, a Pediatrics paper highlighted. The trials demonstrated that PENBRAYA has robust immunogenicity non-inferior to Trumenba (meningococcal group B vaccine) and Menveo ® for all serogroups and was well-tolerated with a favourable safety profile.

Food and Drug Administration 105

Food and Drug Administration Safety Food FDA 105

European Pharmaceutical Review

APRIL 17, 2024

Roche multiple sclerosis subcutaneous injection: late-breaking data “Updated results from OCARINA II further underline the potential benefits of subcutaneous OCREVUS for patients with both relapsing and progressive forms of MS,” shared Scott Newsome , DO, lead author, Johns Hopkins University School of Medicine.

Food and Drug Administration 93

Food and Drug Administration Safety Medicine Food 93

European Pharmaceutical Review

APRIL 5, 2024

For people with [propionic acidaemia], harmful amounts of toxic metabolites can build up in the body and lead to metabolic decompensation events and multisystemic complications. The post mRNA therapy could provide intracellular protein replacement for rare disease appeared first on European Pharmaceutical Review.

Side effects 98

Side effects Safety Patients Leads 98

European Pharmaceutical Review

AUGUST 24, 2023

Therefore “This could improve the overall safety and tolerability of risvodetinib.” “… compared to the capsules currently in use in the 201 clinical trial, the smaller tablets may overcome challenges patients have swallowing oral medication as a result of their disease.

Safety 98

Safety Medical Medicine Patients 98